ArticleJournal of assisted reproduction and genetics2026
Protein levels of p-mTOR and p-RPS6 in cumulus cells serve as non-invasive biomarkers for embryo quality and pregnancy outcome in IVF.
Article in Journal of assisted reproduction and genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeTo investigate whether the levels of mTOR signaling and ribosome biogenesis proteins in cumulus cells (CCs) can serve as non-invasive biomarkers for predicting embryo quality and pregnancy outcomes in women undergoing IVF.
methodsIn this prospective study, discarded CCs were collected from 83 IVF patients. The protein levels of mTOR, phosphorylated mTOR (p-mTOR), ribosomal protein S6 (RPS6), and phosphorylated S6 (p-RPS6) were quantified by Western blot and normalized to β-actin. These molecular data were correlated with clinical parameters, including ovarian reserve, embryonic development, and pregnancy outcomes. Statistical analyses were performed to determine optimal predictive thresholds and to evaluate single and combined protein models.
resultsReduced levels of p-mTOR, p-RPS6, and RPS6 in CCs were robustly associated with superior IVF outcomes. Specific cutoff values were identified (e.g., p-mTOR < 0.45, p-RPS6 < 0.80) for predicting enhanced blastocyst formation and higher clinical pregnancy rates. Combining these biomarkers into multi-protein models significantly improved predictive accuracy for both embryonic development and pregnancy success compared to any single protein alone.
conclusionThe assessment of p-mTOR, p-RPS6, and RPS6 in cumulus cells provides a powerful, non-invasive strategy for prognostic assessment in IVF. A molecular profile characterized by lower levels of these proteins is indicative of high oocyte developmental competence and a greater likelihood of successful pregnancy, offering a valuable tool for clinical decision-making prior to embryo transfer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.